Our Company
About Us
About Xanamem
®
(emestedastat)
Our Team
Recent Annual Reports
Our Strategic Priorities
Corporate Governance
Xanamem
®
(emestedastat)
The Cortisol Hypothesis
Mechanism of Action
Publications
Clinical Trials
Clinical Development Pipeline
Cognitive Impairment in early Alzheimer’s Disease
Cognitive Impairment in MDD
Anxiety, sleep & behavioral problems in Fragile X Syndrome
Patient Portal
Participate in clinical trials
The XanaMIA Phase 2b/3 Alzheimer’s Trial
Publications
Investor Centre
Share Price
ASX Announcements
Press Releases
Corporate Presentations
Analyst Reports
Financial Results Centre
Annual General Meeting
General Meeting
Financial Calendar
Target Market Determination
Right to Receive Documents
Frequently Asked Questions
Investor Contacts
News
Contact Us
News
Latest Summary Corporate Presentation
May 2025
View Presentation
All updates and Media
Press Releases and Media
Corporate Presentations
All
2023
2022
2021
2020
2019
2018
2017
2016
2015
15 May 2025
Webcast Video Recording
ACW Clinical Trials Science Forum 2025 – The critical importance of preparing for commercialization [1.00 hr]
24 Jan 2025
Actinogen
Executive Interview: Edison Group interviews Dr Steven Gourlay (23m39s)
12 Jan 2025
Actinogen
Video recording: Actinogen Medical at the Sachs Neuroscience Innovation Forum 2025 (17m: 44s)
18 Sep 2024
Actinogen
Webcast Video Recording: ACW $11.1 capital raising
30 Aug 2024
Actinogen
Webcast Video Recording: Actinogen updated Depression Trial results and implications presentation
12 Aug 2024
Actinogen
Webcast Video Recording: Actinogen XanaCIDD topline results presentation
03 Jun 2024
Actinogen
Video Recording: ACW Australian Dementia Research Forum poster presentation
24 May 2024
Actinogen
Webcast Video Recording: Actinogen Clinical Trials Science Forum 2024 – Pipeline in a Pill
06 May 2024
Actinogen
Video interview: [2:49 mins] Market Link interview with ACW CEO, Steven Gourlay
03 May 2024
Corporate Presentations
Video Presentation: Actinogen May 2024 $8.9m capital raising webinar
08 Jan 2024
Corporate Presentations
Company Presentation: ACW CEO & CMO present at Sachs Neuroscience Innovation Forum & JPM week meetings
07 Jan 2024
Corporate Presentations
Video Presentation: ACW CMO presents at Sachs Neuroscience Innovation Forum
15 Nov 2023
Corporate Presentations
Company Presentation: ACW CEO presents at Bell Potter Healthcare Conference 2023
25 Oct 2023
Corporate Presentations
Company Presentation: ACW CMO presents academic poster at CTAD 2023 conference
18 Oct 2023
Corporate Presentations
Company Presentation: ACW CEO presentation for meetings at BIO Investor Forum USA
06 Oct 2023
Actinogen
Company Presentation: ACW CEO presents to Dementia Trials Australia conference
29 Sep 2023
Actinogen
Company Presentation: ACW Clinical Scientist presents to the Asian Society Against Dementia congress
14 Sep 2023
Actinogen
Video interview: [14.46 mins] Xanamem program update
31 Aug 2023
Media
Webcast video recording: Actinogen neuroscience webinar
24 May 2023
Actinogen
Webcast video recording: Actinogen Clinical Trials Science Forum 2023
30 Mar 2023
Actinogen
Oral presentation: CMO presentation at Alzheimer’s and Parkinson’s Disease Conference (AD/PD™) in Gothenburg, Sweden
24 Feb 2023
Actinogen
Company presentation: Spark Plus Biotech Conference in Singapore
09 Jan 2023
Actinogen
Company presentation: Sachs Neuroscience Innovation Forum and other meetings during the JP Morgan Healthcare Conference week
Back
to top
